BRAND OPTIMISATION PLAYBOOK
Advisory boards
BRAND OPTIMISATION PLAYBOOK
Advisory
boards
Real-world to test strategy,
real clinical
Real-world insight to test strategy, clarify evidence needs and reveal real clinical decision-making.
We work with you to define the challenges, shape the agenda, recruit the most relevant experts and create the conditions for open, exploratory discussion – so insight goes beyond validation and leads to clear next steps.
Designed and delivered in line with ABPI requirements, our advisory boards are independently facilitated and typically completed within 6–8 weeks (subject to expert availability).
Following the meeting, you receive a structured, objective report capturing:
- Key themes and tensions
- Areas of consensus uncertainty
- Practical recommendations to inform strategy, access, engagement or evidence planning
Driving brand success
Advisory boards
in practice
Complete
compliance
Designed and delivered in line with ABPI requirements with independent facilitation
Stronger market
understanding
Clearer insight into clinical practice and system dynamics to inform brand strategy
Clearer access
pathway
Prioritised evidence gaps and stakeholder requirements to support access and value planning
Improved field
effectiveness
Practical insight into messages, objections and engagement priorities grounded in real-world feedback
Stronger launch
foundations
Insight-led positioning and a clearer value narrative to support confident launch decisions
Sustained
engagement
planning
Documented insight to inform ongoing stakeholder engagement and next-stage planning
An advisory board
success story
The challenge
A pharma client planned to introduce a European product into the UK market. While the product had a solid reputation in France and other European markets, the UK presented distinct challenges, including equity and access barriers, limited awareness among clinicians, and uncertainty around evidence from UK decision-makers.
The solution
We convened a UK advisory board of well-positioned KOLs to gather targeted, real-world insight. Discussion focused on clinical evidence expectations, patient selection, positioning considerations, evidence-generation priorities, and access and equity factors influencing adoption.
The resulting insight report set out a clear evidence roadmap, market access considerations and engagement priorities – strengthening the client’s understanding of the UK landscape and providing confidence to shape next-stage launch and access planning.
Need guidance?
LET US:
- Define: Your objectives, critical challenges, priority stakeholders and the questions that need answers
- Design: An agenda and materials that encourage open discussion and challenge assumptions
- Deliver: An independently facilitated session with structured, objective insight capture aligned to ABPI requirements
- Translate: Insights into clear, actionable recommendations that inform strategy, access planning and next steps for success
Need guidance?
LET US:
- Define: Your objectives, critical challenges, priority stakeholders and the questions that need answers
- Design: An agenda and materials that encourage open discussion and challenge assumptions
- Deliver: An independently facilitated session with structured, objective insight capture aligned to ABPI requirements
- Translate: Insights into clear, actionable recommendations that inform strategy, access planning and next steps for success
